Fig. 8
Working model of the study. Schematic depiction of the mechanism underlying O-GlcNAcylation of YTHDF2-mediated HBV-related HCC progression by stabilizing m6A-modified MCM2/5
Fig. 8 | Signal Transduction and Targeted Therapy
Working model of the study. Schematic depiction of the mechanism underlying O-GlcNAcylation of YTHDF2-mediated HBV-related HCC progression by stabilizing m6A-modified MCM2/5
